References
1. Govani FS, Shovlin CL. Hereditary haemorrhagic telangiectasia: a clinical and scientific review. Eur J Hum Genet. 2009 Jul;17(7):860-71. doi: 10.1038/ejhg.2009.35. Epub 2009 Apr 1. PMID: 193373
2. Dakeishi M, Shioya T, Wada Y, Shindo T, Otaka K, Manabe M, et al. Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mutat. (2002) 19:140–8. 10.1002/humu.10026
3. Shovlin CL, Buscarini E, Kjeldsen AD, Mager HJ, Sabba C, Droege F, et al. European reference network for rare vascular diseases (VASCERN) outcome measures for hereditary haemorrhagic telangiectasia (HHT). Orphanet J Rare Dis. (2018) 13:136. 10.1186/s13023-018-0850-2
4. Donaldson JW, McKeever TM, Hall IP, Hubbard RB, Fogarty AW. The UK prevalence of hereditary haemorrhagic telangiectasia and its association with sex, socioeconomic status and region of residence: a population-based study. Thorax. 2014 Feb;69(2):161-7. doi: 10.1136/thoraxjnl-2013-203720. Epub 2013 Nov 4. PMID: 24188926.
5. McDonald J, Stevenson DA. Hereditary Hemorrhagic Telangiectasia. 2000 Jun 26 [updated 2021 Nov 24]. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023. PMID: 20301525
6. Macri A, Wilson AM, Shafaat O, Sharma S: Osler-Weber-Rendu Disease. StatPearls [Internet], Treasure Island (FL); 2021.
7. Jackson SB, Villano NP, Benhammou JN, Lewis M, Pisegna JR, Padua D. Gastrointestinal Manifestations of Hereditary Hemorrhagic Telangiectasia (HHT): A Systematic Review of the Literature. Dig Dis Sci. 2017 Oct;62(10):2623-2630.
8. Morgan T, McDonald J, Anderson C, Ismail M, Miller F, Mao R, Madan A, Barnes P, Hudgins L, Manning M. Intracranial hemorrhage in infants and children with hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome). Pediatrics. 2002 Jan;109(1):E12.
9. Garg N, Khunger M, Gupta A, Kumar N. Optimal management of hereditary hemorrhagic telangiectasia. J Blood Med. (2014) 5:191–206. 10.2147/JBM.S45295.
10. Pahl KS, Choudhury A, Wusik K, Hammill A, White A, Henderson K, et al. Applicability of the curaçao criteria for the diagnosis of hereditary hemorrhagic telangiectasia in the pediatric population. J Pediatr. (2018) 197:207–13. 10.1016/j.jpeds.2018.01.079).
11. Sabbà C. A rare and misdiagnosed bleeding disorder: hereditary hemorrhagic telangiectasia. J ThrombHaemost 2005; 3(10): 2201–2210
12. Report of the National Commission on Orphan Disease. Executive summary and recommendations. Washington, DC: US Department Of Health And Human Services, 1989.
13. Lisa S. Hereditary Hemorrhagic Telangiectasia-NORD (National Organization for Rare Disorders).” NORD (National Organization for Rare Disorders). 2021. Available at: rarediseases.org. Accessed on May 10, 2022.
14. Athena K, Al-Samkari H, Kuter DJ. Hereditary Hemorrhagic Telangiectasia: Diagnosis and Management from the Hematologist’s Perspective. Haematologica.” Hereditary Hemorrhagic Telangiectasia: Diagnosis and Management from the Hematologist’s Perspective. Haematologica. 2018; 103(9):1-5.
15. Faughnan ME, Palda VA, Garcia-Tsao G, et al. International guidelines for the diagnosis and management of hereditary haemorrhagictelangiectasia.J Med Genet. 2011;48(2):73–87
16. Plauchu H, Chadarévian D, Bideau A, Robert JM. Age‐related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet. 1989; 32(3):291–7.
17. Haitjema T, Balder W, Disch FJM, Westermann CJJ. Epistaxis in hereditary hemorrhagic telangiectasia. Rhinology 1996; 34:176-8.
18. Gallitelli M, Pasculli G, Fiore T, Carella A, Sabbà C. Emergencies in hereditary haemorrhagic telangiectasia. QJM. 2006; 99(1):15–22.
19. Amanzada A, Töppler GJ, Cameron S, Schwörer H, Ramadori G: A case report of a patient with hereditary hemorrhagic telangiectasia treated successively with thalidomide and bevacizumab. Case Rep Oncol. 2010, 3:463-470. 10.1159/000323152
20. dos Santos JWA, Dalcin TC, Neves KR, Mann KC, Pretto GLN, Bertolazi AN. Hereditary hemorrhagic telangiectasia: a rare cause of severe anemia. J Bras Pneumol 2007; 33(1):109-12.
21. Kasthuri RS, Montifar M, Nelson J, Kim H, Lawton MT, Faughnan ME; Brain Vascular Malformation Consortium HHT Investigator Group. Prevalence and predictors of anemia in hereditary hemorrhagic telangiectasia. Am J Hematol. 2017 Jun 22:10.1002/ajh.24832. doi: 10.1002/ajh.24832. Epub ahead of print. PMID: 28639385; PMCID: PMC5997494.
22. Kristy Pahl, Arkopal Choudhury, Raj S. Kasthuri; Causes and Severity of Anemia in Hereditary Hemorrhagic Telangiectasia. Blood 2016; 128 (22): 3776. doi: https://doi.org/10.1182/blood.V128.22.3776.3776
23. Garcia-Tsao G, Korzenik JR, Young L, Henderson KJ, Jain D, Byrd B, Pollak JS, White RI Jr. Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2000; 343:931–6
24. Begbie M, Wallace G, Shovlin C. Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century. Postgrad Med J. 2003; 79(927):18–24.
25. Shovlin CL: Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev. 2010, 24:203-219. 10.1016/j.blre.2010.07.001
26. Amanzada A, Töppler GJ, Cameron S, Schwörer H, Ramadori G. A case report of a patient with hereditary hemorrhagic telangiectasia treated successively with thalidomide and bevacizumab. Case Rep Oncol. 2010 Sep; 3(3):463-70. doi: 10.1159/000323152. Epub 2010 Dec 11. PMID: 21611144; PMCID: PMC3100268.
27. Bown SG, Swain CP, Storey DW, et al. Endoscopic laser treatment of vascular anomalies of the upper gastrointestinal tract. Gut. 1985; 26(12):1338–1348.
28. Sargeant IR, Loizou LA, Rampton D, Tulloch M, Bown SG. Laser ablation of upper gastrointestinal vascular ectasias: long term results. Gut. 1993; 34(4):470–475.